← FDA Drug Approvals (Drugs@FDA)
TEVETEN
NDA · New Drug Application · Sponsor: ABBVIE · Approved 1997-12-22
Drug application
- FDA Application #
NDA020738- Application type
- New Drug Application
- Brand name
- TEVETEN
- Generic name
- Eprosartan Mesylate
- Active ingredients
- EPROSARTAN MESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ABBVIE
- First approval
- 1997-12-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown